Autism Stem Cell Therapy Patent Application Filed

Published: August 1, 2007, 12:05 pm

Tags: autism research, autism disorder, patent application, stem cell autism treatment, medistem laboratories inc

Medistem Laboratories Inc., the company whose researchers published the recent stem cell treatment proposal in the Journal of Translational Medicine has applied for a patent in respect of its stem cell therapy which covers patient selection, therapeutic combinations and various stem cell types. Hopefully the patent, if granted, promotes further research and development in this area, and if the treatment is proven effective and beneficial to autistic patients, does not render the price of treatment beyond reach for generations.Medistem Announces Autism Stem Cell Therapy Paper and Filing of IP Aug 1 2007, 5:05 AM EST MARKETWIRE Aug 01, 2007 SCOTTSDALE, AZ MARKET WIRE Medistem Laboratories, Inc. (OTCBB: MDSM) (FRANKFURT: S2U) announced today the filing of IP and publication of a peer reviewed paper describing a novel method of selecting specific subsets of autistic patients for treatment with a combination of cellular therapies. "Based on positive case report data from one of our

[ Full article ]

Blog link

Rating: 0

Comments